Group 1 - The company reported a revenue of 549 million yuan for the first half of 2025, representing a year-on-year growth of 5.39% [1] - The net profit attributable to shareholders of the listed company was 28.28 million yuan, showing a year-on-year increase of 21.81% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 24.85 million yuan, which is a year-on-year growth of 15.39% [1] - The basic earnings per share were 0.1061 yuan [1]

证券代码：301009 证券简称：可靠股份 公告编号：2025-034 杭州可靠护理用品股份有限公司 关于聘任公司副总经理、董事会秘书的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 杭州可靠护理用品股份有限公司（以下简称"公司"）于 2025 年 8 月 21 日召开了第五届董事会第十一次会议，审议通过了《关于聘任公司副总经理的议 案》及《关于聘任公司董事会秘书的议案》。经公司董事长兼总经理金利伟先生 提名，并经董事会提名委员会资格审核通过，董事会同意聘任王向亭先生为公司 副总经理、董事会秘书（简历附后），任期自本次董事会审议通过之日起至第五 届董事会届满为止。 王向亭先生已取得深圳证券交易所颁发的董事会秘书资格证书，熟悉履职相 关的法律法规、具备与岗位要求相适应的职业操守、具备相应的专业胜任能力与 从业经验，其任职资格符合《公司法》《深圳证券交易所上市公司自律监管指引 第 2 号——创业板上市公司规范运作》及《公司章程》的有关规定，不存在法律 法规及其他规范性文件规定的不得担任上市公司高级管理人员及董事会秘书的 情形。 王向亭先生联系方式如下： 联系 ...

证券代码：301009 证券简称：可靠股份 公告编号：2025-033 杭州可靠护理用品股份有限公司 关于 2025 年半年度募集资金存放与使用情况的专项报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚 假记载、误导性陈述或重大遗漏。 根据《上市公司募集资金监管规则》《深圳证券交易所上市公司自律监管指 引第 2 号——创业板上市公司规范运作》及相关格式指引的规定，杭州可靠护理 用品股份有限公司（以下简称"公司"或"本公司"）编制的 2025 年半年度募集 资金存放与使用情况报告如下： 一、募集资金基本情况 （一）实际募集资金金额和资金到账时间 根据中国证券监督管理委员会《关于同意杭州可靠护理用品股份有限公司首 次公开发行股票注册的批复》（证监许可〔2021〕1630 号），本公司由主承销 商国泰海通证券股份有限公司（原国泰君安证券股份有限公司）采用向战略投资 者定向配售、网下向符合条件的投资者询价配售和网上向持有深圳市场非限售 A 股股份或非限售存托凭证市值的社会公众投资者定价发行相结合的方式，向社会 公众公开发行人民币普通股（A 股）股票 6,797.00 万股，发行价为每股人民币 ...

2025半年度非经营性资金占用及其他关联资金往来情况汇总表 编制单位：杭州可靠护理用品股份有限公司 单位：人民币万元 | 非经营性资金占用 | 资金占用方名称 | 占用方与上市公 | 上市公司核算的 | 2025年期初 | 2025半年度占用 累计发生金额 | 2025半年度占用 资金的利息 | 2025半年度偿还 | 2025半年度期末 | 占用形成原因 | 占用性质 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 司的关联关系 | 会计科目 | 占用资金余额 | | | 累计发生金额 | 占用资金余额 | | | | | | | | | （不含利息） | （如有） | | | | | | 控股股东、实际控制人及其附属企 | | | | | | | | | | 非经营性占用 | | 业 | | | | | | | | | | 非经营性占用 | | 小 计 | - | - | - | | | | | | | - | | 前控股股东、实际控制人及其附属 | | | | | | | | | | 非经营性占用 | ...

杭州可靠护理用品股份有限公司（以下简称"公司"）第五届监事会第十次 会议于 2025 年 8 月 21 日在杭州市余杭区向往街 1118 号英国中心 T6-28 层公司 会议室以现场表决的方式召开。会议通知已于 2025 年 8 月 11 日以电话及电子邮 件等方式送达各位监事。本次会议应出席监事 3 人，实际出席监事 3 人。会议由 监事会主席任绍楠先生主持，会议召开符合有关法律、法规、规章和《公司章程》 的规定。 证券代码：301009 证券简称：可靠股份 公告编号：2025-030 杭州可靠护理用品股份有限公司 第五届监事会第十次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 二、监事会会议审议情况 1、审议通过《关于<2025 年半年度报告及其摘要>的议案》 经审议，监事会认为：公司《2025 年半年度报告》及《2025 年半年度报告 摘要》的编制和审核程序符合法律、行政法规和中国证监会的有关规定，报告内 容真实、准确、完整地反映了公司 2025 年半年度经营的实际情况，不存在虚假 记载、误导性陈述或者重大遗漏。 ...

证券代码：301009 证券简称：可靠股份 公告编号：2025-029 杭州可靠护理用品股份有限公司 第五届董事会第十一次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 杭州可靠护理用品股份有限公司（以下简称"公司"）第五届董事会第十一 次会议于 2025 年 8 月 21 日在杭州市余杭区向往街 1118 号英国中心 T6-28 层公 司会议室以现场及网络会议相结合的方式召开，会议通知已于 2025 年 8 月 11 日以电话及电子邮件等方式送达各位董事。本次会议应出席董事 7 人，实际出席 董事 7 人（其中董事鲍佳女士、独立董事景乃权先生以网络会议在线参会并审议 表决），会议由董事长金利伟先生主持，公司监事及高级管理人员列席。会议召 开符合有关法律、法规、规章和《公司章程》的规定。 二、董事会会议审议情况 1、审议通过《关于<2025 年半年度报告及其摘要>的议案》 《2025 年半年度报告》及《2025 年半年度报告摘要》具体内容详见公司同 日披露在巨潮资讯网（www.cninfo.com.cn）的相关公告。 本议 ...

Group 1 - Reliable Co., Ltd. held its 11th meeting of the 5th Board of Directors on August 21, 2025, in Hangzhou, discussing the appointment of the board secretary and other documents [1] - For the year 2024, the revenue composition of Reliable Co., Ltd. is 100.0% from the paper products industry [1] Group 2 - As of the report, the market capitalization of Reliable Co., Ltd. is 4.4 billion yuan [2]

Financial Performance - The company's operating revenue for the first half of 2025 was CNY 548,955,995.93, representing a 5.39% increase compared to CNY 520,871,114.13 in the same period last year[27]. - The net profit attributable to shareholders of the listed company reached CNY 28,278,610.82, up 21.81% from CNY 23,215,048.45 year-on-year[27]. - Basic earnings per share rose to CNY 0.1061, a 23.52% increase from CNY 0.0859 in the same period last year[27]. - The net profit after deducting non-recurring gains and losses was CNY 24,845,974.42, which is a 15.39% increase from CNY 21,532,421.53 in the same period last year[27]. - The total comprehensive income for the first half of 2025 was ¥28,591,750.49, compared to ¥23,388,540.36 in the first half of 2024, an increase of 22.3%[178]. - The company reported a net profit for the first half of 2025 of ¥28,590,975.77, representing a 22.5% increase from ¥23,389,686.84 in the first half of 2024[178]. - The total revenue for the period was 10,074 million, with a year-over-year growth of 2.4%[188]. - The company reported a profit of 659 million yuan for the current period, maintaining the same level as the previous year[189]. Cash Flow and Investments - The net cash flow from operating activities significantly increased by 157.71%, amounting to CNY 41,375,461.65 compared to CNY 16,055,201.76 in the previous year[27]. - Cash inflow from operating activities totaled ¥659,302,473.20 in the first half of 2025, compared to ¥638,464,199.22 in the first half of 2024, indicating an increase of 3.9%[182]. - The total cash inflow from investment activities in the first half of 2025 was 61,699,139.29, while cash outflow was 10,142,255.00, resulting in a net cash flow of 51,556,884.29[185]. - The company received 58,630,000.00 in cash from investment recoveries during the first half of 2025, indicating active management of investment portfolios[185]. - The company reported a total of CNY 59.30 million in entrusted financial management, with no overdue amounts or impairments recorded[85]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,101,522,895.96, reflecting a 0.57% increase from CNY 2,089,561,649.59 at the end of the previous year[27]. - Total liabilities increased slightly to ¥679,557,750.34 from ¥678,058,135.61, reflecting a growth of approximately 0.2%[171]. - The company's total assets amounted to 1.3 billion, indicating a stable financial position[188]. - The total liabilities of the company were reported at 1.4 billion, maintaining a healthy debt-to-equity ratio[188]. Research and Development - The company’s R&D investment rose by 5.82% to approximately ¥22.99 million, reflecting its commitment to product innovation[59]. - Research and development expenses for the first half of 2025 were ¥22,985,260.34, slightly up from ¥21,720,127.36 in the first half of 2024, reflecting a growth of 5.8%[177]. - The company has completed 20 research projects and participated in drafting 4 national and group standards related to aging products, enhancing its influence in the silver economy sector[56]. Market Strategy and Product Development - The company has established a clear business matrix focusing on high-growth potential self-owned brands in adult care and mature ODM models for baby and pet health care[34]. - The company is enhancing its market position by transitioning from basic functionality to pursuing extreme performance experiences, exemplified by the upgrade of its flagship product "Absorbent Treasure" to version 2.0[35]. - The company has identified a significant market opportunity in light urinary incontinence, with a reported incidence rate of 30.9% among Chinese women, and has developed innovative products to address this need[36]. - The company aims to expand its product line, including the introduction of products specifically designed for light incontinence, targeting a growing consumer awareness in this segment[55]. - The company plans to expand its market presence through strategic acquisitions and new product launches in the upcoming quarters[188]. Shareholder and Governance Matters - The company plans to distribute a cash dividend of RMB 0.70 per 10 shares, totaling RMB 18,649,694, with no stock dividends or capital reserve transfers[106]. - The company has established a comprehensive investor rights protection system to enhance transparency and communication with investors[105]. - The company has committed to irrevocably waive voting rights for 10,874,400 shares, representing 4% of the total shares as of the commitment date[112]. - The company has established measures to ensure compliance with its commitments, including potential penalties for non-compliance[123]. - The commitments made by the company's shareholders and management are long-term and will be adhered to[123]. Risks and Challenges - The company emphasizes the importance of risk awareness regarding future plans and development strategies, indicating potential risks in its operations[9]. - The company faces risks from increasing market competition, requiring effective strategic planning to maintain operational performance[92]. - Fluctuations in raw material prices pose a risk to product costs and profitability, prompting the company to extend its operations upstream to secure core raw materials[92]. - The company is addressing challenges in marketing channel expansion due to economic shifts and consumer behavior, focusing on product innovation and channel development to enhance market competitiveness[92]. Corporate Social Responsibility - The company actively participates in social responsibility initiatives, including support for disabled individuals and community health education[110]. - The company emphasizes environmental management and has developed biodegradable hygiene products to promote sustainable development[104].

Market Overview - The personal care products sector increased by 0.74% on August 21, with Jieya Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 3771.1, up 0.13%, while the Shenzhen Component Index closed at 11919.76, down 0.06% [1] Stock Performance - Jieya Co., Ltd. (301108) closed at 30.18, up 10.23% with a trading volume of 73,200 shares and a turnover of 219 million yuan [1] - Yiyi Co., Ltd. (001206) closed at 27.01, up 3.17% with a trading volume of 99,000 shares and a turnover of 265 million yuan [1] - Zhongshun Jierou (002511) closed at 8.91, up 2.65% with a trading volume of 450,700 shares and a turnover of 403 million yuan [1] - Other notable performances include: - Liangmian Needle (600249) up 1.36% - Beijia Clean (603059) up 1.13% - Wanjian Medical (300888) up 0.62% [1] Capital Flow - The personal care products sector experienced a net outflow of 42.6484 million yuan from institutional investors, while retail investors saw a net inflow of 67.9388 million yuan [2] - The detailed capital flow for key stocks shows: - Wanjian Medical had a net inflow of 23.3464 million yuan from institutional investors [3] - Jieya Co., Ltd. had a net inflow of 9.9211 million yuan from institutional investors [3] - Zhongshun Jierou had a net inflow of 1.121 million yuan from retail investors [3]

Market Overview - The Shanghai Composite Index rose by 1.04% on August 20, with 30 industries experiencing gains, led by the beauty and personal care sector, which increased by 2.42% [1] - The oil and petrochemical industry followed closely with a rise of 2.36% [1] - The pharmaceutical and biotechnology sector was the only industry to decline, with a decrease of 0.07% [1] Capital Flow Analysis - The net outflow of capital from the two markets was 30.229 billion yuan, with 10 industries seeing net inflows [1] - The electronics industry had the highest net inflow, amounting to 5.522 billion yuan, and it rose by 2.32% [1] - The food and beverage sector also saw a positive net inflow of 2.494 billion yuan, with a daily increase of 1.39% [1] Beauty and Personal Care Sector - The beauty and personal care industry experienced a rise of 2.42%, with a net inflow of 351 million yuan [2] - Out of 29 stocks in this sector, 22 stocks increased while 7 stocks decreased [2] - The top three stocks with the highest net inflow were Qingdao Kingking (111.57 million yuan), Proya (90.199 million yuan), and Shanghai Jahwa (67.136 million yuan) [2][3] Individual Stock Performance - Qingdao Kingking had a daily increase of 3.84% with a turnover rate of 20.38% and a net capital flow of 111.5719 million yuan [3] - Proya and Shanghai Jahwa also performed well, with increases of 3.66% and 6.21%, respectively [3] - The stocks with the highest net outflows included Reliable Shares (51.0926 million yuan), Hao Yue Care (21.4761 million yuan), and Qingsong Shares (18.5760 million yuan) [4]